fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Chronic Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, K; Imai, M; Kawai, Y; Kawakami, U; Mizuno, T; Morio, M; Negishi, A; Ogasawara, Y; Satoh, N; Tamura, T | 1 |
1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Chronic Disease
| Article | Year |
|---|---|
Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts.
Topics: Absorption; Acute Disease; Anesthetics; Animals; Calcium Compounds; Carbon Dioxide; Chronic Disease; Ethers; Female; Hydrocarbons, Fluorinated; Male; Methyl Ethers; Mutagenicity Tests; Oxides; Rats; Rats, Wistar; Sevoflurane; Sodium Hydroxide | 1992 |